These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 15312967
1. Impaired conditioned taste aversion learning in APP transgenic mice. Janus C, Welzl H, Hanna A, Lovasic L, Lane N, St George-Hyslop P, Westaway D. Neurobiol Aging; 2004 Oct; 25(9):1213-9. PubMed ID: 15312967 [Abstract] [Full Text] [Related]
2. Amyloid beta and impairment in multiple memory systems in older transgenic APP TgCRND8 mice. Hanna A, Horne P, Yager D, Eckman C, Eckman E, Janus C. Genes Brain Behav; 2009 Oct; 8(7):676-84. PubMed ID: 19531156 [Abstract] [Full Text] [Related]
3. Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease. Lovasic L, Bauschke H, Janus C. Genes Brain Behav; 2005 Apr; 4(3):197-208. PubMed ID: 15810906 [Abstract] [Full Text] [Related]
4. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL, Vassar R, Disterhoft JF. Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434 [Abstract] [Full Text] [Related]
5. Metallothionein-I and -III expression in animal models of Alzheimer disease. Carrasco J, Adlard P, Cotman C, Quintana A, Penkowa M, Xu F, Van Nostrand WE, Hidalgo J. Neuroscience; 2006 Dec 28; 143(4):911-22. PubMed ID: 17027170 [Abstract] [Full Text] [Related]
7. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice. Bernardo A, Harrison FE, McCord M, Zhao J, Bruchey A, Davies SS, Jackson Roberts L, Mathews PM, Matsuoka Y, Ariga T, Yu RK, Thompson R, McDonald MP. Neurobiol Aging; 2009 Nov 28; 30(11):1777-91. PubMed ID: 18258340 [Abstract] [Full Text] [Related]
10. Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Stover KR, Brown RE. Behav Brain Res; 2012 May 16; 231(1):75-85. PubMed ID: 22409975 [Abstract] [Full Text] [Related]
11. Activity changes and marked stereotypic behavior precede Abeta pathology in TgCRND8 Alzheimer mice. Ambrée O, Touma C, Görtz N, Keyvani K, Paulus W, Palme R, Sachser N. Neurobiol Aging; 2006 Jul 16; 27(7):955-64. PubMed ID: 15993515 [Abstract] [Full Text] [Related]
12. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease. Pérez M, Morán MA, Ferrer I, Avila J, Gómez-Ramos P. Acta Neuropathol; 2008 Oct 16; 116(4):409-18. PubMed ID: 18679696 [Abstract] [Full Text] [Related]
16. Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. O'Leary TP, Brown RE. Behav Brain Res; 2009 Jul 19; 201(1):120-7. PubMed ID: 19428625 [Abstract] [Full Text] [Related]
18. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice. Devi L, Ohno M. Eur J Neurosci; 2010 Jan 19; 31(1):110-8. PubMed ID: 20092558 [Abstract] [Full Text] [Related]
19. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice. Kandimalla KK, Wengenack TM, Curran GL, Gilles EJ, Poduslo JF. J Pharmacol Exp Ther; 2007 Aug 19; 322(2):541-9. PubMed ID: 17505020 [Abstract] [Full Text] [Related]
20. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease. He J, Luo H, Yan B, Yu Y, Wang H, Wei Z, Zhang Y, Xu H, Tempier A, Li X, Li XM. Neurobiol Aging; 2009 Aug 19; 30(8):1205-16. PubMed ID: 18079026 [Abstract] [Full Text] [Related] Page: [Next] [New Search]